|
Indeed....
Hi Lori.
As one of those who:
1. has been through chemotherapy that is acknowledged to be damaging to the heart,
2. then was subjected to tamoxifen that was considered likely to promote further cancer in some HER2's
3. then put on an AI with its limited history and potentially significant adverse long-term effects,
4. then prevented from getting evidence one way or the other about the question of Herceptin as a high-risk Stage 1 patient,
5. and now observing that those newly diagnosed in my category as well as those considered to be at lesser risk are routinely receiving Herceptin,
I too am legitimately concerned about the logic of the categorization process in regard to providing Herceptin for HER2 breast cancer patients.
I don't know if my oncologist understands my thinking about this, but he has tentatively authorized Herceptin for me beginning in January.
AlaskaAngel
|